文献速递肝胆胰外科围术期管理与 ERAS

肝门部胆管癌90天死亡与长期生存的多变量预测模型

Multivariable prediction model for both 90-day mortality and long-term survival for individual patients with perihilar cholangiocarcinoma: does the predicted survival justify the surgical risk?
PubMed 文献 · Br J Surg · 2023-01-01

这项回顾性队列研究基于1673例肝门部胆管癌患者,建立术前预测90天死亡和总生存的多变量模型。模型将患者分为有利、中间和不利三组,有利组90天死亡率5.8%、中位OS 42个月,不利组分别为26.8%和16个月。术前风险模型有助于识别不太可能从手术切除中获益的患者。

要点

  • 术前模型可预测肝门部胆管癌术后90天死亡和长期生存。
  • 有利组90天死亡率5.8%、中位OS 42个月,不利组分别为26.8%和16个月。
  • 中间组占66.2%,需个体化共享决策。

核心结论

  • 术前风险模型可帮助识别可切除肝门部胆管癌中不太可能从手术切除获益的患者。

研究设计与样本

  • 回顾性队列研究,共纳入1673例患者,使用多变量回归分析分别建立90天死亡和总生存的术前预测模型。

主要发现

  • 90天死亡和OS的共同独立危险因素包括ASA III-IV级、大肿瘤直径和右半肝切除。
  • 90天死亡的额外危险因素为高龄和术前胆管炎;长期OS的额外危险因素为高BMI、术前黄疸、Bismuth IV型和肝动脉受累。
  • 有利组294例(17.6%),90天死亡率5.8%,中位OS 42个月。
  • 不利组271例(16.2%),90天死亡率26.8%,中位OS 16个月。
  • 中间组1108例(66.2%),90天死亡率12.5%,中位OS 27个月。

关键数值与推荐

  • 有利组定义:90天死亡率低于10%且预测OS超过3年。
  • 不利组定义:90天死亡率高于25%和/或预测OS低于1.5年。
  • 中间组介于有利和不利组之间。

临床怎么用

  • 术前可使用该模型评估90天死亡和长期生存风险,辅助手术决策。
  • 对中间组患者尤其需要量身定制的共享决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The risk of death after surgery for perihilar cholangiocarcinoma is high; nearly one in every five patients dies within 90 days after surgery. When the oncological benefit is limited, a high-risk resection may not be justified. This retrospective cohort study aimed to create two preoperative prognostic models to predict 90-day mortality and overall survival (OS) after major liver resection for perihilar cholangiocarcinoma. METHODS: Separate models were built with factors known before surgery using multivariable regression analysis for 90-day mortality and OS. Patients were categorized in three groups: favourable profile for surgical resection (90-day mortality rate below 10 per cent and predicted OS more than 3 years), unfavourable profile (90-day mortality rate above 25 per cent and/or predicted OS below 1.5 years), and an intermediate group. RESULTS: A total of 1673 patients were included. Independent risk factors for both 90-day mortality and OS included ASA grade III-IV, large tumour diameter, and right-sided hepatectomy. Additional risk factors for 90-day mortality were advanced age and preoperative cholangitis; those for long-term OS were high BMI, preoperative jaundice, Bismuth IV, and hepatic artery involvement. In total, 294 patients (17.6 per cent) had a favourable risk profile for surgery (90-day mortality rate 5.8 per cent and median OS 42 months), 271 patients (16.2 per cent) an unfavourable risk profile (90-day mortality rate 26.8 per cent and median OS 16 months), and 1108 patients (66.2 per cent) an intermediate risk profile (90-day mortality rate 12.5 per cent and median OS 27 months). CONCLUSION: Preoperative risk models for 90-day mortality and OS can help identify patients with resectable perihilar cholangiocarcinoma who are unlikely to benefit from surgical resection. Tailored shared decision-making is particularly essential for the large intermediate group.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. van Keulen AM, Buettner S, Erdmann JI, et al. Multivariable prediction model for both 90-day mortality and long-term survival for individual patients with perihilar cholangiocarcinoma: does the predicted survival justify the surgical risk? Br J Surg. 2023. PMID: 36918735. doi:10.1093/bjs/znad057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。